What do Oncology prescribers really think of you?
IMS OncoClient, a proprietary, market-leading customer satisfaction survey allows you to confidently understand how Oncology prescribers view you and your brands.
Conducted annually following the ASCO meeting, IMS OncoClient is now available for the fourth consecutive year, delivering a consistent robust service across physicians responsible for treating solid tumour and haematological cancers in the top five European markets.
With IMS OncoClient you can determine:
-
Whether promotional activities are satisfying prescriber information needs - and influencing their behaviour
-
How prescribers benchmark you versus your competitors - are you gaining or losing ground?
-
Whether you are perceived as an Oncology innovator – and is this important to your customers?
-
The key drivers of prescriber satisfaction – how can you get closer to them?
-
How prescribers stay informed about their tumour of interest - which websites do they rely on?
The service helps you:
-
Benchmark your performance across key strategic markets to help you stay ahead of the competition in the oncology arena
-
Identify best practices, take corrective action and optimize brand performance by quantitatively assessing the effectiveness of tactical implementation by your affiliates, pinpointing high and moderate/ low performing geographies
-
Make effective promotional investment decisions - by understanding which promotional activities are most important to your customers
-
Assess how prescriber perceptions of you and your competitors have changed over time, highlighting the need for potential adjustments to promotional strategy and implementation
-
Gain insight to physician communication preferences, including the Internet, to improve future promotional campaigns
If you would like further details on IMS OncoClient, or to schedule an appointment with an IMS Consultant, email us at oncology@uk.imshealth.com.
For our other information assets visit the Our Solutions section of this site.